Performance Characteristics of Different Anti-Double-Stranded DNA Antibody Assays in the Monitoring of Systemic Lupus Erythematosus

Figure 1

Anti-dsDNA titers and disease activity in all individual patients. Anti-dsDNA antibody titers measured at each monthly study visit are presented along with the clinical SELENA-SLEDAI and physician’s global assessment (PGA × 10) at each visit.